Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI

Similar documents
Coverage Guidelines. NMR LipoProfile and NMR LipoProfile -II Tests

Lipoprotein Particle Profile


BIOCHEMISTRY BLOOD - SERUM Result Range Units

Traceable lipoprotein counting for Cardiovascular disease risk assessment Vincent DELATOUR, PhD

LIPOPROTEIN PROFILING

The New Gold Standard for Lipoprotein Analysis. Advanced Testing for Cardiovascular Risk


Nutrition & Wellness for Life 2012 Chapter 6: Fats: A Concentrated Energy Source

sad EFFECTIVE DATE: POLICY LAST UPDATED:

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Lipid Risk Factors (Novel) in Risk Assessment and Management of Cardiovascular Disease

Chapter VIII: Dr. Sameh Sarray Hlaoui

Nutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source

Lipoprotein Subclasses and Cardiovascular Disease Risk in Insulin-Resistant Diabetes

NOVEL BIOMARKERS IN RISK ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR DISEASE

From HDL Structure to Function - How Structural Information Can Help Address Clinical Need March 17, 2012

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol

Bringing metabolic profiling into clinical practice. Linda Mustelin, MD, PhD, MPH Senior Medical Scientist Nightingale Health

What Else Do You Need to Know? Presenter Disclosure Information. Case 1: Cardiovascular Risk Assessment in a 53-Year-Old Man. Learning Objectives

Lipoprotein (a) Disclosures 2/20/2013. Lipoprotein (a): Should We Measure? Should We Treat? Health Diagnostic Laboratory, Inc. No other disclosures

Lipids Types, Food Sources, Functions

Lipids do not like water! (aka: hydrophobic) Generally insoluble

Insert logo. Linda Main, Dietetic Adviser

Metabolism and Atherogenic Properties of LDL

Maintain Cholesterol

Low-density lipoproteins cause atherosclerotic cardiovascular disease (ASCVD) 1. Evidence from genetic, epidemiologic and clinical studies

Current Challenges in CardioMetabolic Testing. Kenneth French, Director of Clinical Operations

BIOB111_CHBIO - Tutorial activity for Session 12

Cholesterol Levels -- What They Mean, Diet and Treatment

Part 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides

OM s Health Corner Cholesterol & Heart Disease!!

High-Density Lipoprotein Subclass Testing in the Diagnosis and Management of Cardiovascular Disease. Original Policy Date

Measurement of Small Dense Low-density Lipoprotein Particles

From Food to the Bloodstream

Your cholesterol levels. Questions or concerns

Lipoproteins Metabolism

Gender: M Chart No: Fasting: Yes. Boston Heart HDL Map TM Test 1 ApoA-I (mg/dl) levels in HDL particles. α Range > <14 mg/dl. α-2 50.

Fats and Other Lipids

MMBS, MMED (Path),MAACB, MACTM, MACRRM

Nature Genetics: doi: /ng.3561

Lipids, pt. 1. Feb. 3, Bio 28: Nutrition Instructor: Paul Nagami Laney College

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!!

Dr. Jonathan Spages D.C.

CARDIO Test INFAI. for Cardiac Risk Assessment

Pathophysiology of Lipid Disorders

Fats, Oils, Triglycerides. About which Americans seem confused

REAGENTS. RANDOX sdldl CHOLESTEROL (sdldl-c) SIZE MATTERS: THE TRUE WEIGHT OF RISK IN LIPID PROFILING

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Cholesterol, Heart Attack and Stroke. Dr Tai E Shyong Consultant Department of Endocrinology Singapore General Hospital

5. THE ROLE OF LIPIDS IN THE DEVELOPMENT OF ATHEROSCLEROSIS AND CORONARY HEART DISEASE: GUIDELINES FOR DIAGNOSIS AND TREATMENT

High density lipoprotein metabolism

High-density lipoproteins: A consensus statement from the National Lipid Association

ENERGY NUTRIENTS: THE BIG PICTURE WHY WE EAT FUNCTIONS FATS FAT, CARBS, PROTEIN

Measurement of Trigly ceride-rich Lipoproteins by Nuclear Magnetic Resonance Spectroscopy

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS

Hypertriglyceridemia: Why, When, and How to Treat. Gregory Cohn, MD, FNLA, FASPC

Understanding Cholesterol Holistically

Where are we heading?

2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries

Topic 11. Coronary Artery Disease

History. Aron first proposed that fat may be essential for normal growth Tested on animals-vitamins A,D,E added. Fat deficiency severely affected

Test Definition: FNMR2 NMR LipoProfile w/ir Markers

Weight Loss NOTES. [Diploma in Weight Loss]

PREDIABETES TESTING SERVICES

Tracking a Killer Molecule

Lipid Markers. Independent Risk Factors. Insulin Resistance Score by Lipid Fractionation

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W.

Lipids are used to store and excess energy from extra carbohydrates in animals

Free food = 20 calories per serving

POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) Term-End Examination June, 2015

Low-fat dietary pattern and lipoprotein risk factors: the Women s Health Initiative Dietary Modification Trial 1 4

numares at a glance company overview 2014 Discover, understand and use biological systems high level NMR analytics

Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry

Review of guidelines for management of dyslipidemia in diabetic patients

EATING FOR A HEALTHY HEART S A R A Z O O K, R D N, C D, C P H W C

Plasma lipoproteins & atherosclerosis by. Prof.Dr. Maha M. Sallam

Are you eating a balanced diet?

Diet, nutrition and cardio vascular diseases. By Dr. Mona Mortada

Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins

Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial

!!! Aggregate Report Fasting Biometric Screening CLIENT!XXXX. May 2, ,000 participants

What Are Lipids? FaWy Acids Are Key Building Blocks. Lipids Include. Chapter 5 Lipids: Not Just Fat 6/17/16

DIFFERENT METHODS FOR PARTICLE DIAMETER DETERMINATION OF LOW DENSITY AND HIGH DENSITY LIPOPROTEINS COMPARISON AND EVALUATION.

Incorporating HDL interaction in an ODE model of Atherosclerosis

Chapter (5) Etiology of Low HDL- Cholesterol

Chest pain affects 20% to 40% of the general population during their lifetime.

Lipids. PBHL 211 Darine Hachem, MS, LD

Do Cholesterol Numbers Really Assess Cardiovascular Risk?

Cardio IQ. Managing Residual Risk with Advanced Cardiovascular Insights. Plaque Formation. Outward remodeling of arterial wall. Macrophages ingest

The coronary arteries are located along the outside of the heart as seen here which assist in this process.

ADVANCED CARDIOMETABOLIC SCREENING

ANSC/NUTR 618 LIPIDS & LIPID METABOLISM Lipoprotein Metabolism

Low-density lipoprotein as the key factor in atherogenesis too high, too long, or both

Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL

Katsuyuki Nakajima, PhD. Member of JCCLS International Committee

Biomarkers (Novel) in Risk Assessment and Management of Cardiovascular Disease

CHAPTER FORTY FIVE ENDOGENOUS LIPID TRANSPORT PATHWAY: VLDL AND IDL


Transcription:

Walter B. Bayubay CLS (ASCP), AMT, MA Ed, CPI

Biochemical Analysis (Lipid Panel) Analyte Total Cholesterol Reference Range Patient A < 200 241 LDL-C <130 180 HDL-C >/= 40 38 Triglycerides <150 267 Patient B 180 100 42 140

LIPOPROTEINS are macromolecular complexes that serve as transport vehicle of insoluble lipids in the plasma.

Structure of Lipoprotein

Five Main Classes of Lipoproteins: Chylomicrons Very Low Density Lipoprotein (VLDL) Intermediate Density Lipoprotein (IDL) Low Density Lipoprotein (LDL) High Density Lipoprotein (HDL)

RELATIVE SIZES OF LIPOPROTEINS

RELATIVE COMPOSITION OF LIPOPROTEINS

HDL vs. LDL

HDL vs. LDL

HDL vs. LDL

Methods of Lipoprotein Estimation Gradient Gel Electrophoresis Ultracentrifugation - Vertical Auto Profile (VAP) Nuclear Magnetic Resonance (NMR) Ion Mobility - Gas-phase Electrophoresis

Gradient Gel Electrophoresis HDL and LDL run in separate polyacrylamide gels Gradients are segmented into different regions LDL 3 segments (S 3 GGE) HDL - 10 segments (S 10 GGE) Segmenting gradient permits better separation of subfractions HDL analysis requires purification of HDL before GGE Lipoproteins identified by lipid (LDL) or protein (HDL) stain Concentrations or relative concentrations determined based on scan of separated lipoproteins

Ultracentrifugation Vertical Auto Profile (VAP) Vertical auto profile (VAP) method is a direct single test for measuring comprehensive lipoprotein cholesterol profile. It is based on a well-established method of ultracentrifugation that uses vertical rotor and single density gradient spin.

Ultracentrifugation Vertical Auto Profile (VAP) VAP provides cholesterol concentrations of total lipoprotein, high-density lipoprotein (HDL), lowdensity lipoprotein (LDL), very-low-density lipoprotein (VLDL), lipoprotein(a) (Lp(a)), intermediate-density lipoprotein (IDL), HDL subclasses (HDL2 and HDL3), LDL subclasses (LDL1, LDL2, LDL3, and LDL4), VLDL subclasses (VLDL1, VLDL2, and VLDL3), and LDL maximum time, which is directly proportional to LDL size.

Ultracentrifugation Vertical Auto Profile (VAP) Because VAP measures additional lipoprotein classes, such as Lp(a), IDL, and subclasses of HDL, LDL, and VLDL, it can identify patients at high risk for coronary heart disease who cannot be identified using the standard lipid panel. In addition, the VAP method is compliant with the National Cholesterol Education Program's Adult Treatment Panel III guidelines.

Nuclear Magnetic Resonance (NMR) Nuclear magnetic resonance (NMR) spectroscopy measures the number and size of lipoprotein particles instead of their cholesterol or triglyceride content, but its clinical utility is uncertain. Lipoprotein concentrations and size determined from a H-NMR scan of serum No sample preparation required

Nuclear Magnetic Resonance (NMR) In one study, cardiovascular disease risk prediction associated with lipoprotein profiles evaluated by NMR was comparable but not superior to that of standard lipids or apolipoproteins. In another study, the magnitude of predictive value of LDL particle concentration (NMR) was not substantively different from that of the total cholesterol to HDL cholesterol ratio and was less than that of C-reactive protein.

LIPOPROTEIN FRACTIONATION

Ion Mobility Ion mobility lipoprotein fractionation is a technology that uses gas-phase (laminar flow) electrophoresis to separate unmodified lipoproteins on the basis of size. Involves electrophoretic separation of particles in laminar air-flow (Gas-Phase Electrophoretic Macromolecular Mobility Analyzer GEMMA) Technique used routinely to determine particle distributions in aerosol analysis

Ion Mobility The size of the lipoprotein particles detected and counted are not affected by particle modifications. (unique property of this method) Ionized lipoprotein particles are electrophoretically separated in a gas phase, and lipoprotein particles are distinguished on the basis of size.

Ion Mobility Following the separation, each lipoprotein particle is directly detected and counted as it exits the separation chamber. Size-separated particles are detected and counted by light scattering.

Ion Mobility Separation of Lipoprotein

Ion Mobility Components Sample Introduction Separation Detection Spray & Dry Aerosol analyzer Detector analyzer voltage light beam Air + CO 2 + HV - a source +1 ions Condenser Liquid Sample filter blower Saturated vapor in detector

Unit of Measure The ångström (Å) (0.1 nm) is a unit of measure denoting the diameter (size) of a particle. This diameter is used to determine the pattern A vs pattern B LDL phenotype.

Pattern A is classified as optimal, and pattern B is classified as high risk. This is based on large population studies showing that people without coronary heart disease tend to have an abundance of large, buoyant LDL particles (pattern A), and people with coronary heart disease tend to have an abundance of smaller, dense LDL particles (pattern B). 7

Ideal profile

Fractionation by Ion Mobility HDL (alpha) - small - large IDL - small - large LDL (beta) - very small - small plus medium - large VLDL (pre-beta) - small - medium - large

Fractionation by Ion Mobility HDL LDL IDL VLDL - small - large - very small - small plus medium - large - small - large - small - medium - large

CVD Risk Associations The following CVD risk associations were observed in the Malmo Diet and Cancer Study cardiovascular cohort 2 : High number of small LDL particles: 1.3 times increased risk High number of medium LDL particles: 1.4 times increased risk Low number of large HDL particles: 1.8 times increased risk

Ion Mobility vs. Electrophoresis

Ideal profile

HDL Large equivalent to Apo A1 Apolipoprotein A1 A major protein component of HDL in plasma Promotes fat efflux (including cholesterol), from tissues to the liver for excretion Also isolated as a prostacyclin (PGI2) stabilizing factor, and thus may have an anticlotting effect A stronger prognostic marker for cardiovascular disease

Ideal profile

LDL Medium + Small concentration - gives better information than LDL-C - principally made of Apo B Apolipoprotein B (Apo B) Major apolipoprotein component of LDL and chylomicrons Responsible for carrying cholesterol to tissues Can lead to plaques that cause vascular disease (atherosclerosis) leading to heart disease Better indicator of heart disease risk than LDL or Total Cholesterol

Pattern A vs Pattern B

Type B Profile indicates high risk for coronary heart disease

Type A Profile indicative of low risk for coronary heart disease

Before After

Before After

Analyte Reference Range Patient B Total Cholesterol <200 180 LDL-C <130 100 HDL-C >/= 40 42 Triglycerides <150 140

Lipoprotein Sub-fraction Reference Ranges Lipoprotein Subtype Females LDL, Peak Diameter 216.0-234.3 Angstrom Males 216.0-234.3 Angstrom LDL, Total 396-1461 nmol/l 440-1600 nmol/l LDL, Medium + Small 105-521 nmol/l 144-787 nmol/l LDL, Very Small 77-293 nmol/l 75-419 nmol/l Non-HDL 571-2003 nmol/l 582-2142 nmol/l HDL, Large 1153-7796 nmol/l 469-5258 nmol/l

Lipoprotein Sub-fraction Reference Ranges GOALS Lipoprotein Subtype LDL, Peak Diameter LDL, Total LDL, Medium + Small LDL, Very Small HDL, Large Females and Males > 216.0 Angstrom < 915 nmol/l < 304 nmol/l < 218 nmol/l < 3017 nmol/l

Conclusions: Eighty percent of individuals suffering from coronary heart disease (CAD) have normal cholesterol levels. Half of the 1.5 million heart attacks in the U.S. each year strike people without symptoms also have normal cholesterol levels. Lipid analysis is the only screening test for determining at risk individuals BUT it misses 50% of at risk individuals

Lipoprotein fractionation by Ion Mobility offers ability to interrogate lipoproteins within specific groups, HDL, LDL LDL medium + small concentration gives better information than LDL-C (Apo B) HDL large equivalent to HDL-C (Apo A1) LDL particle diameter and concentration used in evaluating therapeutic options

Ion mobility provides accurate, reproducible, direct determination of size and concentration for a broad range of lipoprotein particles.

Balance Diet

Balance Diet

Foods that elevate levels of HDL Cholesterol Raw onions ½ of a medium size raw onion can raise HDL as much as 25% Omega-3 fatty acids Include fish, green vegetables and canola oil Soluble fiber Beans, oats, whole grains, fruits like apples, pears and raspberries Monounsaturated fats Olive oil and canola oil

Exercise

THE END Thank you for listening.